Key Record Dates Identifier: NCT00974584
Brief Title: A Study of the Safety and Pharmacology Of PI3-Kinase Inhibitor GDC-0941 In Combination With Either Paclitaxel And Carboplatin (With or Without Bevacizumab) or Pemetrexed, Cisplatin, And Bevacizumab in Patients With Advanced Non-Small Cell Lung Cancer

First Submitted : September 8, 2009
First Submitted that Met QC Criteria : September 8, 2009
First Posted : September 10, 2009 (Estimate)

Last Update Submitted that Met QC Criteria : November 1, 2016
Last Update Posted : November 2, 2016 (Estimate)